| Dpmpunniprpa Llc | |
|
1923 Welsh Rd, Philadelphia, PA 19115-4659 | |
| (215) 677-3222 | |
| (215) 677-3241 |
| Full Name | Dpmpunniprpa Llc |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 1923 Welsh Rd, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043523780 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | SC006182 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dpmpunniprpa Llc 1923 Welsh Rd, Philadelphia, PA 19115-4659 Ph: (215) 677-3222 | Dpmpunniprpa Llc 1923 Welsh Rd, Philadelphia, PA 19115-4659 Ph: (215) 677-3222 |
News Archive
Researchers at the New York University Grossman School of Medicine and Biohaven Pharmaceuticals found that the REGN10933 and REGN10987 combination was 9.1-fold less potent on the B.1.351 variant, which emerged in South Africa, and 16.2-fold less potent on mink cluster 5.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that its MagniFuse™ Bone Graft has generated its first $1 million in revenue during the four month period beginning with the limited launch of the product in late October 2009. Osteotech began the first phase of its strategic limited launch of MagniFuse with the release of three procedure specific forms for posterior cervical and posterolateral spine fusion and spinal deformity procedures.
AB SCIEX, a global leader in life science analytical technologies, and Phenomenex, a global leader in separation science techniques, today announced a collaboration agreement designed to significantly improve food testing.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, Rhei Pharmaceuticals HK Ltd., received regulatory and marketing approval for MuGard in China from the State Food and Drug Administration, or SFDA, to treat oral mucositis in cancer patients.
People living in northern and central parts of the U.S. are more likely to contract Lyme disease and other tick-borne ailments when white-footed mice are abundant. Mice are effective at transferring disease-causing pathogens to feeding ticks. And, according to an in-press paper in the journal Ecology, these "super hosts" appear indifferent to larval tick infestations.
› Verified 8 days ago
Regina Snow, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 5800 Ridge Ave, Philadelphia, PA 19128 Phone: 215-487-4284 | |
Josephine Depalma Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2706 N 5th St, Philadelphia, PA 19133 Phone: 215-425-5060 Fax: 215-483-9679 | |
Ms. Jennifer Chang - Ching Van, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 148 N 8th St, Philadelphia, PA 19107 Phone: 215-777-5808 Fax: 215-777-5825 | |
Dr. Shaun M Latshaw, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 8835 Germantown Ave, Philadelphia, PA 19118 Phone: 610-428-2427 | |
Dr. Noah Jan Goldman, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 7919 Verree Rd, Philadelphia, PA 19111 Phone: 215-742-8383 | |
Kushkaran Kaur, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 973-975-7383 | |
Dr. Victoria M. Adeniran, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 5800 Ridge Avenue, Philadelphia, PA 19128 Phone: 215-483-9900 |